Company intelligence / Profile preview

Afon Technology

Caldicot, Wales/Monmouthshire, United Kingdomafontechnology.com ↗

Ownership: Private
Employees: ~11
Development stage: Preclinical

Overview

Afon Technology has developed Glucowear™, a non-invasive, wrist-worn continuous blood glucose monitor using ultra-low power RF/microwave technology. The device has undergone several independent clinical trials, including ongoing NHS studies. The company received a €2.5 million European Innovation Council grant in December 2022 to support further development and scale-up. Commercial launch targeted for 2025.

Therapeutic areas: Endocrinology
Modalities: Device (non-invasive continuous glucose monitor)
Industry: Physiological Monitoring

Partnerships

Royal Liverpool Hospital (early clinical collaboration)

Beyond the preview

Go deeper on Afon Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Afon Technology.

Explore the full profile